CXCL12 and type 2 diabetes mellitus: Taken together, high serum levels of SDF-1α could be a sign of platelet activation in both BP and T2D patients and in elderly controls (73), but it seems that the decline of circulating SDF-1α is a BP-independent gliptin-induced phenomenon.